Pentanoic acid,4-(benzoylamino)-5-(dipropylamino)-5-oxo- cas no:6620-60-6
Synonyms: Milid;Milide;Nulsa;Proglumide;Promid;Promide (parasympatholytic);Ulcutin;W 5219;Xyde;Xylamide;Xylamide(gastroprotective agent);Glutaramicacid, 4-benzamido-N,N-dipropyl-, DL- (8CI);Pentanoic acid,4-(benzoylamino)-5-(dipropylamino)-5-oxo-, (?à)-;Binoside;CR 242;DL-4-Benzamido-N,N-dipropylglutaramicacid;DL-Proglumide;Gastrotopic;Midelid;Pentanoic acid, 4-(benzoylamino)-5-(dipropylamino)-5-oxo-, (±)-;
NamePentanoic acid,4-(benzoylamino)-5-(dipropylamino)-5-oxo-
CAS6620-60-6
SynonymsMilid;Milide;Nulsa;Proglumide;Promid;Promide (parasympatholytic);Ulcutin;W 5219;Xyde;Xylamide;Xylamide(gastroprotective agent);Glutaramicacid, 4-benzamido-N,N-dipropyl-, DL- (8CI);Pentanoic acid,4-(benzoylamino)-5-(dipropylamino)-5-oxo-, (?à)-;Binoside;CR 242;DL-4-Benzamido-N,N-dipropylglutaramicacid;DL-Proglumide;Gastrotopic;Midelid;Pentanoic acid, 4-(benzoylamino)-5-(dipropylamino)-5-oxo-, (±)-;
EINECS(EC#)229-567-4
Molecular FormulaC18H26N2O4
Molecular Weight334.41004
AppearanceWhite crystalline powder
refractive index1.534
storage tempRefrigerator
Safety
Moderately toxic by several routes. An experimental teratogen. When heated to decomposition it emits toxic fumes of NOx.
| Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
| mouse |
LD50 |
intraperitoneal |
1480mg/kg (1480mg/kg) |
|
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 20, Pg. 447, 1978. |
| mouse |
LD50 |
intravenous |
2250mg/kg (2250mg/kg) |
|
Minerva Medica. Vol. 58, Pg. 3653, 1967. |
| mouse |
LD50 |
oral |
2250mg/kg (2250mg/kg) |
|
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 10, Pg. 892, 1968. |
| mouse |
LD50 |
subcutaneous |
> 5190mg/kg (5190mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
SKIN AND APPENDAGES (SKIN): CORROSIVE: AFTER TOPICAL EXPOSURE
ENDOCRINE: OTHER CHANGES |
Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 203, 1971. |
| rat |
LD50 |
intraperitoneal |
1420mg/kg (1420mg/kg) |
|
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 20, Pg. 447, 1978. |
| rat |
LD50 |
oral |
20gm/kg (20000mg/kg) |
|
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 20, Pg. 447, 1978. |
| rat |
LD50 |
subcutaneous |
> 5190mg/kg (5190mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
ENDOCRINE: OTHER CHANGES
SKIN AND APPENDAGES (SKIN): CORROSIVE: AFTER TOPICAL EXPOSURE |
Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 203, 1971. |
